Skip to main content
. 2022 Apr 12;11(8):e024722. doi: 10.1161/JAHA.121.024722

Table 1.

Patient Demographic and Clinical Characteristics

Characteristics

Overall

(n=1386)

Index age <10 y

(n=622)

Index age 10–18 y

(n=764)

P value
Race or ethnicity, n (%)* 0.448
White 379 (53.2) 163 (50.5) 216 (55.5)
Black 82 (11.5) 39 (12.1) 43 (11.1)
Hispanic 50 (7.0) 28 (8.7) 22 (5.7)
Other 7 (1.0) 4 (1.2) 3 (0.8)
Unknown 194 (27.3) 89 (27.5) 105 (26.9)
Region, n (%)* 0.209
Northeast 116 (17.2) 49 (16.4) 67 (8.8)
North central 166 (24.6) 62 (20.7) 104 (13.6)
South 243 (36.1) 115 (38.5) 128 (16.8)
West 133 (19.7) 66 (22.1) 67 (8.8)
Unknown 16 (2.4) 7(2.3) 9 (2.4)
Insurance, n (%) 0.707
Commercial 674 (48.6) 299 (48.1) 375 (49.1)
Medicaid 712 (51.4) 323 (51.9) 389 (50.9)
Follow‐up duration, y, median (Q1–Q3) 3.0 (1.9–4.7) 3.9 (2.0–5.3) 2.5 (1.7–4.0) <0.001
Heart failure, n (%) 75 (5.4) 18 (2.9) 57 (7.5) <0.001
Dilated or other cardiomyopathy, n (%) 211 (15.2) 40 (6.4) 171 (22.4) <0.001
Hypertrophic cardiomyopathy, n (%) 10 (0.7) 2 (0.3) 8 (1.1) 0.200
Respiratory failure, n (%) 144 (10.4) 34 (5.5) 110 (14.4) <0.001
CCCs, n (%)
≥1 CCC 431 (31.1) 180 (28.9) 251 (32.9) 0.117
CCC categories, n (%)
Renal 43 (3.1) 24 (3.9) 19 (2.5) 0.143
Gastrointestinal 110 (7.9) 43 (6.9) 67 (8.8) 0.203
Hematologic/immunologic 35 (2.5) 22 (3.5) 13 (1.7) 0.030
Metabolic 215 (15.5) 99 (15.9) 116 (15.2) 0.708
Malignancy 52 (3.8) 23 (3.7) 29 (3.8) 0.924
Premature/neonatal 18 (1.3) 14 (2.3) 4 (0.5) 0.005
Transplant 5 (0.4) 2 (0.3) 3 (0.4) 0.999
Technology dependence 169 (12.2) 50 (8.0) 119 (15.6) <0.001
Death, n (%) 14 (1.0) 0 (0.0) 14 (1.8) <0.001

CCC indicates complex chronic condition; Q1, quartile 1; and Q3, quartile 3.

*

Region was reported in the Commercial database only; race or ethnicity was reported in the Medicaid database only.

The “Other” race/ethnicity category includes those not identified in the above mentioned groups.